The influence of PD-L1 rs2297136 polymorphism on the clinical outcomes of postoperative colorectal cancer patients receiving capecitabine-based adjuvant chemotherapy
ZHANG Huijian 1 , LIU Dianwen 2 , ZHOU Xiaoli 2 , LIU Yonggang 3 , LI Min 2 , LIU Shiju 2
1. School of Acupuncture, Moxibustion and Tuina, Henan University of Traditional Chinese Medicine, Zhengzhou 450000, Henan Province, China; 2. Department of Anus and Intestine Surgery, the Third Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450000, Henan Province, China; 3. Department of General Surgery, Tumor Hospital of Henan Province, Zhengzhou 450000, Henan Province, China
ZHANG Huijian,LIU Dianwen,ZHOU Xiaoli,LIU Yonggang,LI Min,LIU Shiju . The influence of PD-L1 rs2297136 polymorphism on the clinical outcomes of postoperative colorectal cancer patients receiving capecitabine-based adjuvant chemotherapy[J]. China Oncology, 2019, 29(10): 795-802.